⚖ LexFed
USC CFR Constitution Topics Search Changes About
C.F.R. Title 21 Chapter I Subchapter D Part 341 Subpart C

Code of Federal Regulations · Subpart

Subpart C — Labeling

21 C.F.R. pt. 341, subpt. C

  • § 341.70 Labeling Of Otc Drug Products Containing Ingredients That Are Used For Treating Concurrent Symptoms (in Either A Single-ingredient Or Combination Drug Product)
  • § 341.72 Labeling Of Antihistamine Drug Products
  • § 341.74 Labeling Of Antitussive Drug Products
  • § 341.76 Labeling Of Bronchodilator Drug Products
  • § 341.78 Labeling Of Expectorant Drug Products
  • § 341.80 Labeling Of Nasal Decongestant Drug Products
  • § 341.85 Labeling Of Permitted Combinations Of Active Ingredients
  • § 341.90 Professional Labeling
© 2026 Michigan Legal Publishing Ltd.
Terms of Service Privacy Policy About michlp.com

Disclaimer: LexFed is for informational purposes only and is not a source of legal advice. Federal law text is sourced from OLRC and eCFR bulk data and may not reflect the most recent amendments. Always verify against official government sources before relying on any provision for legal, compliance, or regulatory purposes. AI-generated summaries are illustrative and not legal interpretations.